Biomarker ID | 822 |
PMID | 22142399 |
Year | 2011 |
Biomarker | TDRD1 |
Biomarker Basis | Expression Based |
Biomolecule | mRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated in Prostate cancer |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:-Gene Expression,Mitotic Prophase,PIWI-interacting RNA (piRNA) biogenesis |
Experiment | Benign Vs Tumor |
Type of Biomarker | Diagnostic |
Cohort | 47 prostate tumor tissue samples and in 48 normal prostate tissue samples taken from the non-suspect area of clinical low-risk tumors. GEO Accession: GSE29079. Validation cohort 29 benign and 72 fusion-negative and 48 fusion-positive tumor samples. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | RT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on Independent Patient Cohort |
Technical Name | TDRD1 |